The future of precision medicine starts here
Our mission is to develop novel microbiome-based therapeutics and companion diagnostics aimed at the prevention and treatment of chronic diseases.
See Our Science
Breaking News:
Siolta Therapeutics receives a Grand Challenges Exploration award
The Grand Challenges Exploration (GCE) program, an initiative supported by the Bill & Melinda Gates Foundation, provides grants to address global health challenges. We are honored to have received a grant (GCE Round 22) supporting the development of novel culturing and manufacturing processes for live biotherapeutic products.
Learn More
News
Siolta Therapeutics closes financing round to support clinical development of lead program
Series B – $30 Million
September 22, 2020
Read More
News
FDA grants Fast Track status to Siolta Therapeutics lead clinical program
Fast Track Designation
August 7, 2020
Read More
News
Siolta Therapeutics expands its executive advisory team
Welcome to Dr. John Martin former CEO/Chairperson of Gilead
January 28, 2020
Read More